• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

O-GlcNAc 转移酶抑制作用对乳腺癌亚型具有差异影响。

O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.

机构信息

Department of Tumor Biology, The Norwegian Radium Hospital, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.

Department of Circulation and Medical Imaging, NTNU - Norwegian University of Science and Technology, Trondheim, Norway.

出版信息

Sci Rep. 2019 Apr 5;9(1):5670. doi: 10.1038/s41598-019-42153-6.

DOI:10.1038/s41598-019-42153-6
PMID:30952976
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6450885/
Abstract

Post-translational modification of intracellular proteins with a single N-acetylglucosamine sugar (O-GlcNAcylation) regulates signaling, proliferation, metabolism and protein stability. In breast cancer, expression of the enzyme that catalyzes O-GlcNAcylation - O-GlcNAc-transferase (OGT), and the extent of protein O-GlcNAcylation, are upregulated in tumor tissue, and correlate with cancer progression. Here we compare the significance of O-GlcNAcylation in a panel of breast cancer cells of different phenotypes. We find a greater dependency on OGT among triple-negative breast cancer (TNBC) cell lines, which respond to OGT inhibition by undergoing cell cycle arrest and apoptosis. Searching for the cause of this response, we evaluate the changes in the proteome that occur after OGT inhibition or knock-down, employing a reverse-phase protein array (RPPA). We identify transcriptional repressor - hairy and enhancer of split-1 (HES1) - as a mediator of the OGT inhibition response in the TNBC cells. Inhibition of OGT as well as the loss of HES1 results in potent cytotoxicity and apoptosis. The study raises a possibility of using OGT inhibition to potentiate DNA damage in the TNBC cells.

摘要

细胞内蛋白质的翻译后修饰,单个 N-乙酰葡萄糖胺糖(O-GlcNAcylation),可调节信号转导、增殖、代谢和蛋白质稳定性。在乳腺癌中,催化 O-GlcNAcylation 的酶-O-GlcNAc 转移酶(OGT)的表达,以及蛋白质 O-GlcNAcylation 的程度,在肿瘤组织中上调,并与癌症进展相关。在这里,我们比较了不同表型的一组乳腺癌细胞中 O-GlcNAcylation 的意义。我们发现,三阴性乳腺癌(TNBC)细胞系对 OGT 抑制的依赖性更强,这些细胞通过细胞周期停滞和凋亡对 OGT 抑制作出反应。为了寻找这种反应的原因,我们评估了 OGT 抑制或敲低后发生的蛋白质组变化,采用反相蛋白阵列(RPPA)。我们发现转录抑制因子——毛状和分裂增强子 1(HES1)——是 TNBC 细胞中 OGT 抑制反应的介质。OGT 抑制以及 HES1 的缺失导致强烈的细胞毒性和细胞凋亡。这项研究提出了一种可能性,即使用 OGT 抑制来增强 TNBC 细胞中的 DNA 损伤。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/f9e52e5e35a9/41598_2019_42153_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/62b005df4ac5/41598_2019_42153_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/7bc0c7bbcb6a/41598_2019_42153_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/ac3c9a51fc4f/41598_2019_42153_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/c4585ec0af3a/41598_2019_42153_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/f9e52e5e35a9/41598_2019_42153_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/62b005df4ac5/41598_2019_42153_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/7bc0c7bbcb6a/41598_2019_42153_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/ac3c9a51fc4f/41598_2019_42153_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/c4585ec0af3a/41598_2019_42153_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40c2/6450885/f9e52e5e35a9/41598_2019_42153_Fig5_HTML.jpg

相似文献

1
O-GlcNAc Transferase Inhibition Differentially Affects Breast Cancer Subtypes.O-GlcNAc 转移酶抑制作用对乳腺癌亚型具有差异影响。
Sci Rep. 2019 Apr 5;9(1):5670. doi: 10.1038/s41598-019-42153-6.
2
mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.mTOR/ MYC轴调控乳腺癌中O-连接N-乙酰葡糖胺转移酶的表达及O-连接N-乙酰葡糖胺化修饰
Mol Cancer Res. 2015 May;13(5):923-33. doi: 10.1158/1541-7786.MCR-14-0536. Epub 2015 Jan 30.
3
Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.O-GlcNAc 修饰减少通过 Hsp27 表达及其 O-GlcNAc 修饰影响 MCF-7 细胞的恶性转化。
Oncol Rep. 2018 Oct;40(4):2193-2205. doi: 10.3892/or.2018.6617. Epub 2018 Aug 1.
4
High OGT activity is essential for MYC-driven proliferation of prostate cancer cells.高水平的 OGT 活性对于 MYC 驱动的前列腺癌细胞增殖是必需的。
Theranostics. 2019 Apr 12;9(8):2183-2197. doi: 10.7150/thno.30834. eCollection 2019.
5
Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.OGT 表达受抑制可抑制膀胱癌细胞增殖,诱导细胞凋亡。
BMC Cancer. 2018 Nov 20;18(1):1141. doi: 10.1186/s12885-018-5033-y.
6
Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.O-连接的N-乙酰葡糖胺(O-GlcNAc)糖基化水平升高通过调节细胞周期相关蛋白和细胞外信号调节激酶1/2(ERK 1/2)信号通路促进胃癌细胞增殖。
Oncotarget. 2016 Sep 20;7(38):61390-61402. doi: 10.18632/oncotarget.11359.
7
O-linked N-acetylglucosaminyltransferase OGT inhibits diabetic nephropathy by stabilizing histone methyltransferases EZH2 via the HES1/PTEN axis.O-连接的 N-乙酰氨基葡萄糖基转移酶 OGT 通过 HES1/PTEN 轴稳定组蛋白甲基转移酶 EZH2 来抑制糖尿病肾病。
Life Sci. 2021 Jun 1;274:119226. doi: 10.1016/j.lfs.2021.119226. Epub 2021 Feb 17.
8
Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.高血糖症和O-连接N-乙酰葡糖胺转移酶活性驱动三阴性乳腺癌中的癌症干细胞通路。
Cancer Cell Int. 2023 May 25;23(1):102. doi: 10.1186/s12935-023-02942-6.
9
O-GlcNAc modification affects the ATM-mediated DNA damage response.O-连接的N-乙酰葡糖胺修饰影响ATM介导的DNA损伤反应。
Biochim Biophys Acta. 2012 Oct;1820(10):1678-85. doi: 10.1016/j.bbagen.2012.06.013. Epub 2012 Jul 1.
10
OGT restrains the expansion of DNA damage signaling.O-连接N-乙酰葡糖胺转移酶抑制DNA损伤信号的扩展。
Nucleic Acids Res. 2016 Nov 2;44(19):9266-9278. doi: 10.1093/nar/gkw663. Epub 2016 Jul 25.

引用本文的文献

1
Cell cycle regulation in cancer cells by O-GlcNAcylation.O-连接的N-乙酰葡糖胺糖基化对癌细胞中细胞周期的调控
Glycoconj J. 2025 Aug 18. doi: 10.1007/s10719-025-10189-8.
2
HES1 in cancer: a key player in tumorigenesis and its prognostic significance.癌症中的HES1:肿瘤发生的关键因素及其预后意义
Mol Genet Genomics. 2025 May 20;300(1):49. doi: 10.1007/s00438-025-02259-1.
3
O-GlcNAcylation on serine 40 of histone H2A promotes proliferation and invasion in triple-negative breast cancer.组蛋白H2A第40位丝氨酸上的O-连接N-乙酰葡糖胺化促进三阴性乳腺癌的增殖和侵袭。

本文引用的文献

1
Upregulated SCUBE2 expression in breast cancer stem cells enhances triple negative breast cancer aggression through modulation of notch signaling and epithelial-to-mesenchymal transition.乳腺癌干细胞中 SCUBE2 表达上调通过调节 Notch 信号通路和上皮间质转化增强三阴性乳腺癌的侵袭性。
Exp Cell Res. 2018 Sep 15;370(2):444-453. doi: 10.1016/j.yexcr.2018.07.008. Epub 2018 Jul 5.
2
Metastatic and triple-negative breast cancer: challenges and treatment options.转移性和三阴性乳腺癌:挑战与治疗选择。
Drug Deliv Transl Res. 2018 Oct;8(5):1483-1507. doi: 10.1007/s13346-018-0551-3.
3
BRCA1/2 Mutations and Bevacizumab in the Neoadjuvant Treatment of Breast Cancer: Response and Prognosis Results in Patients With Triple-Negative Breast Cancer From the GeparQuinto Study.
Sci Rep. 2025 Mar 24;15(1):10170. doi: 10.1038/s41598-025-95394-z.
4
The correlation between cellular O-GlcNAcylation and sensitivity to O-GlcNAc inhibitor in colorectal cancer cells.细胞 O-GlcNAcylation 与结直肠癌细胞对 O-GlcNAc 抑制剂敏感性的相关性。
PLoS One. 2024 Oct 16;19(10):e0312173. doi: 10.1371/journal.pone.0312173. eCollection 2024.
5
O-GlcNAcylation: Crosstalk between Hemostasis, Inflammation, and Cancer.O-糖基化:止血、炎症和癌症之间的串扰。
Int J Mol Sci. 2024 Sep 13;25(18):9896. doi: 10.3390/ijms25189896.
6
Breast cancer therapy: from the perspective of glucose metabolism and glycosylation.乳腺癌治疗:从葡萄糖代谢和糖基化的角度。
Mol Biol Rep. 2024 Apr 20;51(1):546. doi: 10.1007/s11033-024-09466-w.
7
Hyperglycemia and O-GlcNAc transferase activity drive a cancer stem cell pathway in triple-negative breast cancer.高血糖症和O-连接N-乙酰葡糖胺转移酶活性驱动三阴性乳腺癌中的癌症干细胞通路。
Cancer Cell Int. 2023 May 25;23(1):102. doi: 10.1186/s12935-023-02942-6.
8
The Emerging Roles of Protein Interactions with O-GlcNAc Cycling Enzymes in Cancer.蛋白质与O-连接的N-乙酰葡糖胺循环酶相互作用在癌症中的新作用
Cancers (Basel). 2022 Oct 20;14(20):5135. doi: 10.3390/cancers14205135.
9
Targeting -GlcNAcylation to overcome resistance to anti-cancer therapies.靶向O-连接N-乙酰葡糖胺化修饰以克服抗癌治疗耐药性
Front Oncol. 2022 Aug 17;12:960312. doi: 10.3389/fonc.2022.960312. eCollection 2022.
10
Suppression of Ca signaling enhances melanoma progression.抑制钙信号增强黑色素瘤进展。
EMBO J. 2022 Oct 4;41(19):e110046. doi: 10.15252/embj.2021110046. Epub 2022 Aug 30.
BRCA1/2 突变与贝伐珠单抗在乳腺癌新辅助治疗中的应用:GeparQuinto 研究中三阴性乳腺癌患者的疗效和预后结果。
J Clin Oncol. 2018 Aug 1;36(22):2281-2287. doi: 10.1200/JCO.2017.77.2285. Epub 2018 May 23.
4
Upregulation of HES1 Promotes Cell Proliferation and Invasion in Breast Cancer as a Prognosis Marker and Therapy Target via the AKT Pathway and EMT Process.HES1的上调通过AKT途径和EMT过程促进乳腺癌细胞增殖和侵袭,作为一种预后标志物和治疗靶点。
J Cancer. 2018 Feb 11;9(4):757-766. doi: 10.7150/jca.22319. eCollection 2018.
5
Cross regulation between mTOR signaling and O-GlcNAcylation.mTOR 信号与 O-GlcNAcylation 的相互调控。
J Bioenerg Biomembr. 2018 Jun;50(3):213-222. doi: 10.1007/s10863-018-9747-y. Epub 2018 Mar 9.
6
Notch1 regulates PTEN expression to exacerbate renal tubulointerstitial fibrosis in diabetic nephropathy by inhibiting autophagy via interactions with Hes1.Notch1通过与Hes1相互作用抑制自噬来调节PTEN表达,从而加剧糖尿病肾病中的肾小管间质纤维化。
Biochem Biophys Res Commun. 2018 Mar 18;497(4):1110-1116. doi: 10.1016/j.bbrc.2018.02.187. Epub 2018 Feb 26.
7
O-GlcNAcylation in women's cancers: breast, endometrial and ovarian.O-GlcNAcylation 在女性癌症中的作用:乳腺癌、子宫内膜癌和卵巢癌。
J Bioenerg Biomembr. 2018 Jun;50(3):199-204. doi: 10.1007/s10863-017-9730-z. Epub 2017 Nov 10.
8
Inhibition of Notch1/Hes1 signaling pathway improves radiosensitivity of colorectal cancer cells.抑制 Notch1/Hes1 信号通路可提高结直肠癌细胞的放射敏感性。
Eur J Pharmacol. 2018 Jan 5;818:364-370. doi: 10.1016/j.ejphar.2017.11.009. Epub 2017 Nov 8.
9
O-GlcNAc-Dependent Regulation of Progesterone Receptor Function in Breast Cancer.O-GlcNAc 依赖性调节乳腺癌中孕激素受体功能。
Horm Cancer. 2018 Feb;9(1):12-21. doi: 10.1007/s12672-017-0310-9. Epub 2017 Sep 19.
10
Activation of STAT3/HIF-1α/Hes-1 axis promotes trastuzumab resistance in HER2-overexpressing breast cancer cells via down-regulation of PTEN.STAT3/HIF-1α/Hes-1 轴的激活通过下调 PTEN 促进了 HER2 过表达乳腺癌细胞对曲妥珠单抗的耐药性。
Biochim Biophys Acta Gen Subj. 2017 Aug;1861(8):1970-1980. doi: 10.1016/j.bbagen.2017.05.009. Epub 2017 May 9.